200,000+ products from a single source!

sales@angenechem.com

Home > Oxazole > 1665-48-1

1665-48-1

1665-48-1 | 2-Oxazolidinone, 5-[(3,5-dimethylphenoxy)methyl]-

CAS No: 1665-48-1 Catalog No: AG001WRZ MDL No:MFCD00867700

Product Description

Catalog Number:
AG001WRZ
Chemical Name:
2-Oxazolidinone, 5-[(3,5-dimethylphenoxy)methyl]-
CAS Number:
1665-48-1
Molecular Formula:
C12H15NO3
Molecular Weight:
221.2524
MDL Number:
MFCD00867700
IUPAC Name:
5-[(3,5-dimethylphenoxy)methyl]-1,3-oxazolidin-2-one
InChI:
InChI=1S/C12H15NO3/c1-8-3-9(2)5-10(4-8)15-7-11-6-13-12(14)16-11/h3-5,11H,6-7H2,1-2H3,(H,13,14)
InChI Key:
IMWZZHHPURKASS-UHFFFAOYSA-N
SMILES:
O=C1NCC(O1)COc1cc(C)cc(c1)C
EC Number:
216-777-6

Properties

Complexity:
247  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
221.105g/mol
Formal Charge:
0
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
221.256g/mol
Monoisotopic Mass:
221.105g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
47.6A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
2.2  

Literature

Title Journal
Metaxalone estimation in biological matrix using high-throughput LC-MS/MS bioanalytical method. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120801
Muscle relaxants for pain management in rheumatoid arthritis. The Cochrane database of systematic reviews 20120118
New Stability-Indicating RP-HPLC Method for Determination of Diclofenac Potassium and Metaxalone from their Combined Dosage Form. Scientia pharmaceutica 20120101
Development of a Stability-Indicating RP-UPLC Method for Rapid Determination of Metaxalone and its Degradation Products in Solid Oral Dosage Form. Scientia pharmaceutica 20120101
In Vitro and In Vivo Study of Poly(ethylene glycol) Conjugated Ibuprofen to Extend the Duration of Action. Scientia pharmaceutica 20110101
Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet journal of rare diseases 20110101
Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method. Healthcare informatics research 20101201
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Pharmaceutical factories as a source of drugs in water. Environmental health perspectives 20100901
Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents. Environmental science & technology 20100701
Pharmacologic management of chronic pain. The Korean journal of pain 20100601
Adult metaxalone ingestions reported to Texas poison control centers, 2000-2006. Human & experimental toxicology 20100101
Pediatric metaxalone ingestions reported to Texas poison control centers, 2000-2007. Pediatric emergency care 20100101
Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clinical interventions in aging 20100101
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors. Bioorganic & medicinal chemistry letters 20091201
Fibromyalgia and myofascial pain syndrome-a dilemma. Indian journal of anaesthesia 20091001
Drugs associated with more suicidal ideations are also associated with more suicide attempts. PloS one 20090101
Choosing a skeletal muscle relaxant. American family physician 20080801
HPLC-ESI-MS/MS validated method for simultaneous quantification of zopiclone and its metabolites, N-desmethyl zopiclone and zopiclone-N-oxide in human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080315
Steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in HIV-infected Ugandan adults. PloS one 20080101
High throughput LC-MS/MS method for simultaneous quantification of lamivudine, stavudine and nevirapine in human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070615
Synthesis of poly(ethylene glycol)-metaxalone conjugates and study of its controlled release in vitro. International journal of pharmaceutics 20070306
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Quantification of metaxalone in human plasma by liquid chromatography coupled to tandem mass spectrometry. Journal of analytical toxicology 20060501
A fatality involving metaxalone. Forensic science international 20050510
Postmortem distribution of tramadol, amitriptyline, and their metabolites in a suicidal overdose. Journal of analytical toxicology 20050101
Auditory hallucinations elicited by combined meclizine and metaxalone use at bedtime. The Annals of pharmacotherapy 20041101
Metaxalone (Skelaxin)-related death. Journal of analytical toxicology 20040901
Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone. Clinical therapeutics 20040901
Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. Journal of pain and symptom management 20040801
Comparison of the dissolution of metaxalone tablets (Skelaxin) using USP Apparatus 2 and 3. AAPS PharmSciTech 20040301
Polydrug fatality involving metaxalone. Journal of forensic sciences 20030301
Centrally acting oral skeletal muscle relaxants. American journal of hospital pharmacy 19801001

© 2019 Angene International Limited. All rights Reserved.